![](https://investorshub.advfn.com/uicon/32556.png?cb=1490101632)
Wednesday, June 01, 2011 1:46:26 PM
![wink](/images/emoticon03.gif)
DELINA FERRETTI
Director, Oncology Clinical Protocol Management, Pfizer Global Research & Development
http://www.jigsaw.com/scid31710894/delina_ferretti.xhtml
Look the 1st Peregrine Contact listed in the Bavi+GEM/Pancreatic Company-Sponsored trial:
“Phase II Trial of Gemcitabine With or Without Bavituximab in Patients With Previously Untreated Stage IV Pancreatic Cancer”
Contact: DELINA FERRETTI
http://clinicaltrials.gov/ct2/show/NCT01272791
Updated Summary of recent Mgt. hires…
5-31-11: Jeff Masten (ex-Genentech Sr.Dir. of Quality) joins Peregrine as VP/Quality http://tinyurl.com/3qxuvso
5-26-11: Dr. Steven Chamow (ex-Genentech) joins Peregrine as Head of Process Science http://tinyurl.com/3bgglxj
5-19-11: Dr. Vladimir Evilevitch (ex-Parexel, ex-Novartis) joins PPHM as Medical Director http://tinyurl.com/3av4red
…"to execute Cotara Regulatory & Clinical strategy"
3-9-11: Dr. Kerstin B. Menander (ex-Abbott) appointed Head of Medical Oncology http://tinyurl.com/4cjlbzn
...”having held senior positions in Abbott Labs, Syntex Labs, Introgen Therapeutics, Collagen Corp., and Cell Pathways, she led the clinical & regulatory strategy and dev. of drugs, biologics, and devices.”
8-2010/(per LinkedIN): Dr. Shelley Suggett (ex-Genentech Senior Product Manager, Genentech Commercial Supply Chain) joins Peregrine as Director of Regulatory Affairs
Of course, it all seemed to start with this:
10-19-09: Dr. Robert Garnick (ex-Genentech) appointed Head/Reg.Affairs http://tinyurl.com/yga7z4x
= = = = = = = = = = =
And, these middle-mgt. adds recently appeared on LinkedIn/ClinicalTrials.gov:
• Kathryn Hansen (ex-Amgen) - Sr. Manager, Regulatory Operations, Peregrine Pharm. (Mar2011-curr)
http://www.linkedin.com/pub/kathryn-hansen/6/a96/960
• Soheila Dadgostari (ex-Valeant) - Sr. Manager, Regulatory Affairs, Peregrine Pharmaceuticals - a/o ~4-16-11
http://www.linkedin.com/company/peregrine-pharmaceuticals
• Delina Ferretti (ex-Pfizer Dir./Oncology Clinical Protocol Mgt.) – don’t know Peregrine title, but she’s 1st contact listed on ClinicalTrials.gov for Ph.2 Bavi+GEM/Pancreatic trial
http://clinicaltrials.gov/ct2/show/nct01272791
Recent CDMO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:50:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:48:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 08:40:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 08:30:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/11/2024 12:23:26 AM
- Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 • GlobeNewswire Inc. • 07/02/2024 08:05:04 PM
- Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 • GlobeNewswire Inc. • 07/01/2024 11:00:21 AM
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
Alliance Creative Group (ACGX) Releases Q2 2024 Financial and Disclosure Report with an increase of over $130,000 in Net Income from Q2 2023 to Q2 2024 • ACGX • Aug 14, 2024 8:30 AM
Avant Technologies Unveils AI-Powered Healthcare Infrastructure to Deliver Intelligent Healthcare Solutions • AVAI • Aug 14, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results • SNWV • Aug 13, 2024 7:11 AM
Kona Gold Beverages, Inc. Nears Completion of Reverse Merger with New Candidate • KGKG • Aug 12, 2024 10:00 AM
Maybacks Global Entertainment and DigiTrax Entertainment Sign Agreement to Broadcast "Karaoke Cloud" on iDreamCTV • AHRO • Aug 12, 2024 8:45 AM
HealthLynked Partners with RxSpark to Enhance Medication Access and Management for Patients • HLYK • Aug 12, 2024 8:00 AM